These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

617 related articles for article (PubMed ID: 18855662)

  • 1. Hyperphosphorylation of microtubule-associated protein tau: a promising therapeutic target for Alzheimer disease.
    Gong CX; Iqbal K
    Curr Med Chem; 2008; 15(23):2321-8. PubMed ID: 18855662
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kinases and phosphatases and tau sites involved in Alzheimer neurofibrillary degeneration.
    Wang JZ; Grundke-Iqbal I; Iqbal K
    Eur J Neurosci; 2007 Jan; 25(1):59-68. PubMed ID: 17241267
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dissociation of tau toxicity and phosphorylation: role of GSK-3beta, MARK and Cdk5 in a Drosophila model.
    Chatterjee S; Sang TK; Lawless GM; Jackson GR
    Hum Mol Genet; 2009 Jan; 18(1):164-77. PubMed ID: 18930955
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of microtubule-associated protein tau phosphorylation in Alzheimer's disease.
    Ma RH; Zhang Y; Hong XY; Zhang JF; Wang JZ; Liu GP
    J Huazhong Univ Sci Technolog Med Sci; 2017 Jun; 37(3):307-312. PubMed ID: 28585125
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytoplasmic retention of protein phosphatase 2A inhibitor 2 (I2PP2A) induces Alzheimer-like abnormal hyperphosphorylation of Tau.
    Arif M; Wei J; Zhang Q; Liu F; Basurto-Islas G; Grundke-Iqbal I; Iqbal K
    J Biol Chem; 2014 Oct; 289(40):27677-91. PubMed ID: 25128526
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of protein phosphatase 2A in Alzheimer's disease.
    Rudrabhatla P; Pant HC
    Curr Alzheimer Res; 2011 Sep; 8(6):623-32. PubMed ID: 21605044
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Involvement of aberrant glycosylation in phosphorylation of tau by cdk5 and GSK-3beta.
    Liu F; Iqbal K; Grundke-Iqbal I; Gong CX
    FEBS Lett; 2002 Oct; 530(1-3):209-14. PubMed ID: 12387894
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microtubule-associated protein tau as a therapeutic target in Alzheimer's disease.
    Iqbal K; Gong CX; Liu F
    Expert Opin Ther Targets; 2014 Mar; 18(3):307-18. PubMed ID: 24387228
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PP2A regulates tau phosphorylation directly and also indirectly via activating GSK-3beta.
    Qian W; Shi J; Yin X; Iqbal K; Grundke-Iqbal I; Gong CX; Liu F
    J Alzheimers Dis; 2010; 19(4):1221-9. PubMed ID: 20308788
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Truncation and activation of GSK-3β by calpain I: a molecular mechanism links to tau hyperphosphorylation in Alzheimer's disease.
    Jin N; Yin X; Yu D; Cao M; Gong CX; Iqbal K; Ding F; Gu X; Liu F
    Sci Rep; 2015 Feb; 5():8187. PubMed ID: 25641096
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dysregulation of insulin signaling, glucose transporters, O-GlcNAcylation, and phosphorylation of tau and neurofilaments in the brain: Implication for Alzheimer's disease.
    Deng Y; Li B; Liu Y; Iqbal K; Grundke-Iqbal I; Gong CX
    Am J Pathol; 2009 Nov; 175(5):2089-98. PubMed ID: 19815707
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tau pathology in Alzheimer disease and other tauopathies.
    Iqbal K; Alonso Adel C; Chen S; Chohan MO; El-Akkad E; Gong CX; Khatoon S; Li B; Liu F; Rahman A; Tanimukai H; Grundke-Iqbal I
    Biochim Biophys Acta; 2005 Jan; 1739(2-3):198-210. PubMed ID: 15615638
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanisms of tau-induced neurodegeneration.
    Iqbal K; Liu F; Gong CX; Alonso Adel C; Grundke-Iqbal I
    Acta Neuropathol; 2009 Jul; 118(1):53-69. PubMed ID: 19184068
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diabetes mellitus and Alzheimer's disease: GSK-3β as a potential link.
    Zhang Y; Huang NQ; Yan F; Jin H; Zhou SY; Shi JS; Jin F
    Behav Brain Res; 2018 Feb; 339():57-65. PubMed ID: 29158110
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phosphorylation of tau by glycogen synthase kinase 3beta in intact mammalian cells influences the stability of microtubules.
    Sang H; Lu Z; Li Y; Ru B; Wang W; Chen J
    Neurosci Lett; 2001 Oct; 312(3):141-4. PubMed ID: 11602330
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phosphorylation of human tau protein by microtubule-associated kinases: GSK3beta and cdk5 are key participants.
    Flaherty DB; Soria JP; Tomasiewicz HG; Wood JG
    J Neurosci Res; 2000 Nov; 62(3):463-72. PubMed ID: 11054815
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SLM, a novel carbazole-based fluorophore attenuates okadaic acid-induced tau hyperphosphorylation via down-regulating GSK-3β activity in SH-SY5Y cells.
    Wu X; Kosaraju J; Tam KY
    Eur J Pharm Sci; 2017 Dec; 110():101-108. PubMed ID: 28359686
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Significance and mechanism of Alzheimer neurofibrillary degeneration and therapeutic targets to inhibit this lesion.
    Iqbal K; Alonso Adel C; El-Akkad E; Gong CX; Haque N; Khatoon S; Pei JJ; Tsujio I; Wang JZ; Grundke-Iqbal I
    J Mol Neurosci; 2002; 19(1-2):95-9. PubMed ID: 12212801
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alzheimer neurofibrillary degeneration: significance, etiopathogenesis, therapeutics and prevention.
    Iqbal K; Grundke-Iqbal I
    J Cell Mol Med; 2008; 12(1):38-55. PubMed ID: 18194444
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glycogen synthase kinase-3 is associated with neuronal and glial hyperphosphorylated tau deposits in Alzheimer's disease, Pick's disease, progressive supranuclear palsy and corticobasal degeneration.
    Ferrer I; Barrachina M; Puig B
    Acta Neuropathol; 2002 Dec; 104(6):583-91. PubMed ID: 12410379
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.